/ Leadership and Faculty

Payel Datta PH.D.

Program Director of Biomanufacturing and Bioprocessing

Dr. Payel Datta is an Assistant Professor in the Department of Pharmaceutical Sciences and a secondary appointment in the Department of Basic and Clinical Sciences at Albany College of Pharmacy and Health Sciences (Albany, New York, USA). As a faculty member of CBET, Dr. Datta’s teaching and mentoring responsibilities include education, workforce development, and mentoring. In addition, Dr. Datta is highly motivated to collaborate on CBET initiatives. Dr. Datta brings over ten years of research experience in mammalian and microbial bioprocessing. Dr. Datta earned her Ph.D. in Biology from Rensselaer Polytechnic Institute (Troy, NY, USA). Her doctoral work focused on understanding the glycobiology of mammalian cells (including CHO cells) and utilizing the knowledge to engineer the CHO proteoglycan pathway. Dr. Datta postdoctoral work focused on developing a 3D live cell imaging system to study cell migration. Dr. Datta served as a researcher at the “Heparin Applied Research Center” at Rensselaer Polytechnic Institute (Troy, NY, USA), where her work focused on R&D in areas of cell biotechnology and bioprocessing. These projects focused on the biomanufacturing of value-added chemicals and required working collaboratively with an interdisciplinary group of scientists from academia and industry. Dr. Datta is highly motivated to harness her expertise and knowledge in teaching, training, and workforce development. Prof. Datta is equally motivated in mentoring students through research in topics related to cell biotechnology and bioprocessing (e.g., how intrinsic and extrinsic factors impact product quality and productivity).


  •  Mammalian Cell Culture (BIO 331 and BIO 631G)
  • Downstream Processing: Purification and Analysis of Biologics (PSC 320 AND PSC 620G)
  • Regulatory Science (PSC 646 G)
  • Training Programs: Principles of Biomanufacturing, Mammalian Cell Culture


  • Understanding the biology of industrially relevant cell systems and emerging/alternate chassis
  • Engineering cells to produce value-added products
  • Evaluating how intrinsic and extrinsic factors impact product quality, and productivity.
  • Value-added Polysaccharides
  • Plasmids (Expression constructs/vectors)
  • Monoclonal antibodies